| Also known as |
Tetrahydrolipstatin |
| Blood pressure |
No direct effect on blood pressure |
| Chemical name |
(S)-((S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl) 2-formamido-4-methylpentanoate |
| Dosage (medical) |
Typically 120 mg three times daily with each main meal containing fat |
| Dosage (sports) |
Not applicable as it is not used for performance enhancement |
| Effects |
Reduces the amount of fat absorbed from the diet |
| Formula |
C29H53NO5 |
| Half-life |
1 to 2 hours |
| Hepatotoxicity |
Rare, but there have been reports of severe liver injury |
| Lab Test |
May interfere with tests for thyroid function |
| Main action |
Inhibits the absorption of fats from the human diet, thereby reducing caloric intake |
| Side effects |
Gastrointestinal issues such as oily spotting, flatulence, abdominal pain, and fecal urgency |
| Storage conditions |
Store at 25В°C (77В°F), excursions permitted to 15-30В°C (59-86В°F) |
| Strength |
120 mg |
| Substance class |
Lipase inhibitor |
| Trade name |
Xenical, Alli |
| Use in sports |
None, as it does not enhance athletic performance |
| Water Retention |
No water retention |
| Manufacturer |
Pharmaceutical |
